Total Payments
$3,490
2024 Payments
$82.07
Companies
16
Transactions
109
Medicare Patients
5,285
Medicare Billing
$227,549
Payment Breakdown by Category
Food & Beverage$3,474 (99.5%)
Education$16.74 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,474 | 108 | 99.5% |
| Education | $16.74 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,448 | 23 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $818.73 | 38 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $405.69 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $215.26 | 13 | $0 (2024) |
| PFIZER INC. | $195.18 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $109.32 | 1 | $0 (2020) |
| iRhythm Technologies, Inc. | $82.59 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $59.34 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $30.86 | 2 | $0 (2023) |
| Amgen Inc. | $29.56 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.07 | 4 | Novartis Pharmaceuticals Corporation ($57.33) |
| 2023 | $215.96 | 10 | E.R. Squibb & Sons, L.L.C. ($161.41) |
| 2022 | $931.49 | 30 | Abbott Laboratories ($415.06) |
| 2021 | $740.40 | 17 | Abbott Laboratories ($375.07) |
| 2020 | $458.58 | 12 | Abbott Laboratories ($249.94) |
| 2019 | $501.68 | 13 | Abbott Laboratories ($384.07) |
| 2018 | $385.09 | 14 | E.R. Squibb & Sons, L.L.C. ($168.05) |
| 2017 | $175.18 | 9 | E.R. Squibb & Sons, L.L.C. ($175.18) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $120.64 | General |
| Category: Cardiovascular | ||||||
| 09/26/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.12 | General |
| Category: Cardiovascular | ||||||
| 08/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.45 | General |
| Category: Cardiovascular | ||||||
| 06/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.02 | General |
| Category: Cardiovascular | ||||||
| 03/15/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Cardiovascular | ||||||
| 03/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.63 | General |
| Category: Cardiovascular | ||||||
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.60 | General |
| Category: Cardiovascular | ||||||
| 01/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.94 | General |
| Category: Cardiovascular | ||||||
| 11/16/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Heart Failure | ||||||
| 10/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.44 | General |
| Category: Cardiovascular | ||||||
| 10/27/2022 | Abbott Laboratories | MINI TREK (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Vascular | ||||||
| 10/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.89 | General |
| Category: Cardiovascular | ||||||
| 10/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $108.59 | General |
| Category: Heart Failure | ||||||
| 09/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Cardiovascular | ||||||
| 09/21/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Heart Failure | ||||||
| 09/01/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $67.93 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,330 | 1,715 | $202,142 | $59,488 |
| 2022 | 18 | 1,661 | 1,936 | $226,263 | $63,877 |
| 2021 | 14 | 1,354 | 1,621 | $162,120 | $60,614 |
| 2020 | 14 | 940 | 1,169 | $136,098 | $43,570 |
Total Patients
5,285
Total Services
6,441
Medicare Billing
$227,549
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 224 | 317 | $36,455 | $21,398 | 58.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 171 | 171 | $51,300 | $9,313 | 18.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 151 | 153 | $34,000 | $7,671 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 43 | 43 | $8,385 | $4,125 | 49.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 35 | 179 | $12,888 | $3,174 | 24.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 131 | 131 | $8,643 | $2,015 | 23.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,225 | $1,917 | 26.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 215 | 319 | $12,652 | $1,880 | 14.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 168 | 168 | $7,248 | $1,705 | 23.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 17 | 17 | $5,746 | $1,269 | 22.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 21 | $3,354 | $1,230 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $2,205 | $954.23 | 43.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 47 | 47 | $3,478 | $832.05 | 23.9% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Facility | 2023 | 11 | 32 | $3,104 | $825.92 | 26.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 22 | 35 | $3,290 | $642.15 | 19.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 16 | $1,270 | $297.28 | 23.4% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 11 | 14 | $644.00 | $199.42 | 31.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 17 | 17 | $255.00 | $39.61 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 198 | 260 | $27,758 | $16,370 | 59.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 257 | 259 | $54,428 | $12,022 | 22.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 185 | 185 | $52,780 | $10,541 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 43 | 43 | $8,520 | $3,801 | 44.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 210 | 211 | $12,965 | $3,140 | 24.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $8,075 | $2,607 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 39 | $4,781 | $2,585 | 54.1% |
About Dr. Michael Codina, MD
Dr. Michael Codina, MD is a Cardiovascular Disease healthcare provider based in Nampa, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871540708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Codina, MD has received a total of $3,490 in payments from pharmaceutical and medical device companies, with $82.07 received in 2024. These payments were reported across 109 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,474).
As a Medicare-enrolled provider, Codina has provided services to 5,285 Medicare beneficiaries, totaling 6,441 services with total Medicare billing of $227,549. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Nampa, ID
- Active Since 05/27/2006
- Last Updated 11/15/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1871540708
Products in Payments
- CardioMEMS HF System (Device) $830.85
- ELIQUIS (Drug) $702.41
- CARDIOMEMS (Device) $397.40
- UPTRAVI (Drug) $266.17
- ENTRESTO (Drug) $172.85
- MitraClip System (Device) $163.87
- CAMZYOS (Drug) $142.71
- Vascepa (Drug) $109.32
- ZIO Patch (Device) $67.36
- XARELTO (Drug) $59.34
- CHANTIX (Drug) $46.29
- LEQVIO (Drug) $42.41
- Repatha (Biological) $29.56
- DEFINITY (Drug) $22.12
- Xience Sierra Coronary Stent System (Device) $20.86
- FARXIGA (Drug) $19.42
- LifeVest (Device) $18.81
- Xience Sierra Coronary Stent (Device) $17.81
- MINI TREK (Device) $17.66
- OPSUMIT (Drug) $16.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Nampa
Dr. Andrew Michaels, M.d, M.D
Cardiovascular Disease — Payments: $11,569
Cardiovascular Disease $11,569
Dr. Rosie Jasper, D.o, D.O
Cardiovascular Disease — Payments: $3,557
Cardiovascular Disease $3,557
Nicholas Hodgman, Md, MD
Cardiovascular Disease — Payments: $2,539
Cardiovascular Disease $2,539
Dr. Randolph Byrd, Md, MD
Cardiovascular Disease — Payments: $599.89
Cardiovascular Disease $599.89
Graham Wetherley, M.d, M.D
Cardiovascular Disease — Payments: $406.46
Cardiovascular Disease $406.46
Dr. Clint Allred, Md, MD
Cardiovascular Disease — Payments: $18.94
Cardiovascular Disease $18.94